119 related articles for article (PubMed ID: 35810606)
1. Incidence of malignancies in patients with multiple sclerosis versus a healthy matched cohort: A population-based cohort study in the Netherlands using the PHARMO Database Network.
Kuiper JG; Overbeek JA; Foch C; Boutmy E; Sabidó M
J Clin Neurosci; 2022 Sep; 103():49-55. PubMed ID: 35810606
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk of cancer among multiple sclerosis patients: A matched population-based cohort study.
Bosco-Lévy P; Foch C; Grelaud A; Sabidó M; Lacueille C; Jové J; Boutmy E; Blin P
Eur J Neurol; 2022 Apr; 29(4):1091-1099. PubMed ID: 34936169
[TBL] [Abstract][Full Text] [Related]
4. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma.
Mahjoub H; Loya A; Ayaz T; Weng CY
Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336
[TBL] [Abstract][Full Text] [Related]
5. Incidence of malignancy in multiple sclerosis: A cohort study in the Danish Multiple Sclerosis Registry.
Nørgaard M; Veres K; Sellebjerg FT; Svingel LS; Foch C; Boutmy E; Sabidó M; Magyari M
Mult Scler J Exp Transl Clin; 2021 Oct; 7(4):20552173211053939. PubMed ID: 34840804
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
7. Comparing the risk of serious infections in patients with and without MS: A German claims data analysis.
Knapp R; Hardtstock F; Wilke T; Maywald U; Chognot C; Craveiro L; Rouzic EM
Mult Scler Relat Disord; 2023 Apr; 72():104583. PubMed ID: 36905817
[TBL] [Abstract][Full Text] [Related]
8. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of malignant diseases in patients with multiple sclerosis: population-based MS Registry data.
Maric G; Pekmezovic T; Mesaros S; Tamas O; Veselinovic N; Budimkic Stefanovic M; Jovanovic A; Drulovic J
Neurol Sci; 2022 Dec; 43(12):6839-6846. PubMed ID: 36040558
[TBL] [Abstract][Full Text] [Related]
10. Incidence of multiple sclerosis in the general population in the Netherlands, 1996-2008.
Kramer MA; van der Maas NA; van Soest EM; Kemmeren JM; de Melker HE; Sturkenboom MC
Neuroepidemiology; 2012; 39(2):96-102. PubMed ID: 22814194
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013.
Rahmattulla C; Berden AE; Wakker SC; Reinders ME; Hagen EC; Wolterbeek R; Bruijn JA; Bajema IM
Arthritis Rheumatol; 2015 Dec; 67(12):3270-8. PubMed ID: 26246307
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety data from the cladribine tablets clinical development program in multiple sclerosis.
Leist T; Cook S; Comi G; Montalban X; Giovannoni G; Nolting A; Damian D; Syed S; Galazka A
Mult Scler Relat Disord; 2020 Nov; 46():102572. PubMed ID: 33296971
[TBL] [Abstract][Full Text] [Related]
13. Risk of cancer among Finnish multiple sclerosis patients.
Hongell K; Kurki S; Sumelahti ML; Soilu-Hänninen M
Mult Scler Relat Disord; 2019 Oct; 35():221-227. PubMed ID: 31404761
[TBL] [Abstract][Full Text] [Related]
14. Cancer Incidence and Mortality Rates in Multiple Sclerosis: A Matched Cohort Study.
Marrie RA; Maxwell C; Mahar A; Ekuma O; McClintock C; Seitz D; Webber C; Groome PA
Neurology; 2021 Jan; 96(4):e501-e512. PubMed ID: 33239364
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis and cancer incidence: A Danish nationwide cohort study.
Nørgaard M; Veres K; Didden EM; Wormser D; Magyari M
Mult Scler Relat Disord; 2019 Feb; 28():81-85. PubMed ID: 30576846
[TBL] [Abstract][Full Text] [Related]
16. Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study.
Buchbinder R; Van Doornum S; Staples M; Lassere M; March L
BMC Musculoskelet Disord; 2015 Oct; 16():309. PubMed ID: 26481039
[TBL] [Abstract][Full Text] [Related]
17. Risk of fractures in patients with multiple sclerosis: a population-based cohort study.
Bazelier MT; van Staa TP; Uitdehaag BM; Cooper C; Leufkens HG; Vestergaard P; Herings RM; de Vries F
Neurology; 2012 Jun; 78(24):1967-73. PubMed ID: 22592374
[TBL] [Abstract][Full Text] [Related]
18. Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study.
McKay KA; Wijnands JMA; Manouchehrinia A; Zhu F; Sereda P; Li J; Ye M; Trigg J; Kooij K; Ekström AM; Gisslén M; Hillert J; Hogg RS; Tremlett H; Kingwell E
Ann Neurol; 2024 Mar; 95(3):487-494. PubMed ID: 38098141
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
[TBL] [Abstract][Full Text] [Related]
20. Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden.
Boffetta P; Gridley G; Lindelöf B
J Invest Dermatol; 2001 Dec; 117(6):1531-7. PubMed ID: 11886519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
